Glucagon-Like Peptide-1 (Glp-1) Analogs Are A Group Of Medications That Are Used For Treating Type 2 Diabetes

Glucagon-Like Peptide-1 (Glp-1) Analogs
Glucagon-Like Peptide-1 (Glp-1) Analogs


Glucagon-Like Peptide-1 Analogs are newer drugs used to treat type 2 diabetes. They regulate glucose levels by stimulating insulin secretion, suppressing glucagon release, and promoting satiety. These effects help control blood sugar, which can help prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function disorders.

Several studies have shown that GLP-1 can also improve lipid metabolism, suppress appetite, and increase fat loss in obese patients. These effects may lead to weight loss and improvement of blood glucose control in type 2 diabetes patients. According to Coherent Market Insights the Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

GLP-1 is produced by three different tissues, which include the enteroendocrine L cells of the distal intestine, alpha cells in the central nervous system, and the pancreas. It acts on the GLP-1 receptor to stimulate insulin secretion, decrease glucagon release and reduce the release of fat from the liver. The release of GLP-1 is stimulated by a wide range of stimuli such as food, activity, and the hormone somatostatin.

The GLP-1 receptor is located in many places throughout the body, including the liver, heart, and stomach. When a person eats, GLP-1 is released from the intestine, enters the blood circulation, and then activates the GLP-1 receptor.

In a healthy person, GLP-1 is broken down by an enzyme called dipeptidyl peptidase-4 in the gastrointestinal tract. In people with diabetes, the body cannot break down enough GLP-1, so a drug is needed to produce more of it.

There are 2 main types of GLP-1 agonists: long-acting (LGLP-1) and short-acting (SGLP-1). Both work by increasing the release of GLP-1 from the intestine and reducing glucagon secretion in the pancreas.

Exenatide, exendin-4, and liraglutide are all available as injectable medications in the United States and Europe. They are injected directly into the vein or stomach, and they are effective for controlling blood sugar in patients who have not improved with a single oral glucose-lowering agent or are on dual therapy.

A randomized, placebo-controlled trial of a once-daily or twice-daily injection of GLP-1 analogs in patients with type 2 diabetes and inadequate glycaemic control on metformin or sulphonylurea has been conducted in the USA. The results showed that the patients who received GLP-1 analogs had significantly better glycaemic control than those who received the placebo or other glucose-lowering agents.

The Mounjaro (tripeptide) injection from Eli Lilly and Company gained approval from the US FDA in May 2022. This injection can be used as an adjunct to diet and exercise for enhancing glycemic control in adult patients suffering from type 2 diabetes.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techn
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories of a
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C
Read more